Previous 10 | Next 10 |
Calyxt has changed its operating strategy to a more conventional agri-bio seed/trait model similar to those pursued by established agri-bio names like Bayer and Corteva. Calyxt is targeting new high-risk/high-reward market opportunities including winter oats, hemp, and soybeans with s...
The following slide deck was published by Calyxt, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Calyxt, Inc. 2020 Q4 - Results - Earnings Call Presentation
Gainers: Second Sight Medical Products (EYES) +337%.AMTD International (HKIB) +27%.Sify Technologies Limited (SIFY) +26%.Boqii Holding Limited (BQ) +25%.ChromaDex Corporation (CDXC) +22%.W&T Offshore (WTI) +21%.Anchiano Therapeutics (ANCN) +18%.Purple Innovation (PRPL) +19%.Plus Ther...
Gainers: Sify Technologies (SIFY) +25%. Moxian (MOXC) +16%. Boqii Holding (BQ) +18%. IMAX (IMAX) +11%. Applied UV (AUVI) +11%.Losers: Super League Gaming, Inc. (SLGG) -38%. Calyxt, Inc. (CLXT) -27%. The Dixie Group, Inc. (DXYN) -27%. Allied Esports Entertainment Inc. (AESE) -24%. Es...
Calyxt, Inc. (CLXT) Q4 2020 Results Conference Call March 04, 2021 04:30 PM ET Company Participants Chris Tyson - EVP, MZ North America Dr. Yves Ribeill - Executive Chair Bill Koschak - CFO Conference Call Participants Bobby Burleson - Canaccord Amit Dayal - H.C. Wainwright Dan Rizzo - Jeffer...
Calyxt (CLXT): Q4 Non-GAAP EPS of -$0.33 misses by $0.10; GAAP EPS of -$0.37 misses by $0.13.Revenue of $13.93M (+270.5% Y/Y) beats by $5.98M.Press Release For further details see: Calyxt EPS misses by $0.10, beats on revenue
Continued to Progress Development of Winter Oats and Hemp, Both Targeted at Large Addressable Markets Secured Commitment from ADM to Purchase Remaining 2019 Grain Inventory and All 2020 Grain Production - Have Completed Sale of 40 Percent of 2020 Grain Crop Executed Commercial Agre...
ROSEVILLE, MN / ACCESSWIRE / March 3, 2021 / Calyxt, Inc . (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor conferences during the month of March 2021: Bank of America Securities 2021 Global Agriculture & Materials Virtual Conference Da...
World-Renowned Plant-Biochemistry Experts Named to Calyxt's Scientific Advisory Board Chaired by Company Co-Founder Dan Voytas, Ph.D. New Strategic Initiative to Identify High Value Plant-Derived Products Utilizing Calyxt's Proprietary Innovation Platform ROSEVILLE, MN / ACCESSWIRE...
Calyxt Secures its First Seed Distribution Agreement Since Advancing Business Model ROSEVILLE, MN / ACCESSWIRE / February 23, 2021 / Calyxt, Inc . (NASDAQ:CLXT), a plant-based technology company, announced today that it has signed a non-exclusive seed distribution agreement with P...
News, Short Squeeze, Breakout and More Instantly...
Shares of Calyxt, Inc. (NASDAQ: CLXT) traded at a new 52-week high today and are currently trading at $5.4. So far today, approximately 55,181 shares have been exchanged, as compared to an average 30-day volume of 89,248 shares. Calyxt, Inc., a synthetic biology company, engages in delivering...
Calyxt Announces Stockholder Approval of Merger With Cibus PR Newswire -- Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock -- ROSEVILLE, Minn. , May 19, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announc...
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update PR Newswire —P roposed merger with Cibus Global Expected to Close in Q2 2023 — —1-for-10 reverse stock split executed— —Current customer...